Myrbetriq ER 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F72WK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,493
Award facts
- Contract value 100% obligated
- $2,492.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,492.95 firm fixed price delivery order to AmerisourceBergen Drug Corp for Myrbetriq ER 25 mg tablets (90-count supply) on December 9, 2025, with completion scheduled for December 10, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health System, supplying a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities.
This delivery order represents a routine pharmaceutical supply transaction under AmerisourceBergen's prime IDC with DLA. The company's federal contract portfolio demonstrates extensive experience fulfilling military healthcare requirements across multiple therapeutic domains, including specialty medications, diabetes treatments, neurological pharmaceuticals, and pain management drugs. As a non-set-aside award made through open competition, this order reflects AmerisourceBergen's competitive capability to meet federal pharmaceutical procurement standards and its role supporting the broader Defense Logistics Agency medical supply chain serving military healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26F72WK?
SPE2DR26F72WK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F72WK worth?
The government has obligated $2,493 on SPE2DR26F72WK.
Is contract SPE2DR26F72WK an order under another contract?
Yes. SPE2DR26F72WK is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F72WK competed?
The extent of competition for SPE2DR26F72WK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award